FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer.
Br J Cancer
; 115(10): 1223-1233, 2016 Nov 08.
Article
in En
| MEDLINE
| ID: mdl-27685445
Full text:
1
Collection:
01-internacional
Health context:
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Cell Death
/
P38 Mitogen-Activated Protein Kinases
/
Cell Proliferation
/
Cetuximab
/
Forkhead Box Protein O3
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Br J Cancer
Year:
2016
Document type:
Article